Pangaea’s investment in Membrion represents a convergence of advanced materials science, technical rigor, impact-driven innovation, and accelerating customer interest, the hallmarks of the companies we champion to drive planetary health. 

Pangaea Ventures and the Arizona Commerce Authority hosted the Semicon West Startup Social during Semicon West’s first conference in Phoenix, a curated gathering of global semiconductor industry leaders highlighting Phoenix’s emergence as a vital node in the global semiconductor ecosystem.

Pangaea Ventures is pleased to announce our participation in Membrion’s $20 Million Series B1 funding, alongside PureTerra, Lam Research, Ecolab, W.L. Gore & Associates., and other existing investors. 

Tidal Grow® Spectra™, developed by Tidal Grow, a division of Pangaea Ventures portfolio company Tidal Vision, has been approved for California specialty crops

Kanvas Biosciences has taken another leap forward with the announcement of their new Good Manufacturing Practices (GMP) facility in South San Francisco.

Aspect Biosystems has released preclinical data highlighting the potential of their adrenal Bioprinted Tissue Therapeutics to restore adrenal function and treat primary adrenal insufficiency.

Vestaron has been granted emergency use approval in Portugal for its SPEAR® LEP bioinsecticide to protect high-value tomato crops from devastating pests.

Pangaea Ventures portfolio company Ardent has reached a major milestone with the commercial implementation of its Optiperm™ olefin-paraffin separation technology by Braskem, the largest polyolefins producer in the Americas.

Pangaea Ventures is proud  to share that AEPONYX, a Pangaea Ventures portfolio company, has been acquired by Pasqal, a global leader in quantum computing.

We're excited to announce our participation in the oversubscribed $18.7M Series A financing for ChEmpower, a company that's pioneering a revolutionary approach to semiconductor manufacturing.

Kanvas Biosciences, a Pangaea Ventures portfolio company, has published new research on its High-Phylogenetic-Resolution Spatial Mapping (HiPR-Map) Platform spectral imaging technology. This novel tool promises to transform how researchers visualize and analyze the complexities of the microbiome.

Calysta and Marsapet have launched the first complete dog food featuring FeedKind Pet protein, a cultured protein fermented without using any arable land or animal ingredients.

ESS Tech, Inc. announced that the company’s global fleet of LDES solutions has transacted nearly 2.5 GWh of transacted energy

The multi-party collaboration will enable embodied carbon reductions at NEOM's large scale construction projects.

Green hydrogen could deliver 10% of required emissions reductions needed to reach net-zero by 2050, particularly in hard-to-decarbonize sectors like heavy industry and long-haul transport.

Our decision to lead the Series C funding round for Green Theme Technologies' (GTT), a company making textile production more sustainable, underscores our commitment to breakthrough technologies that enable better, more sustainable outcomes for industry and the environment

Kanvas Biosciences, a full-stack spatial biology company, announced data from a clinical trial that produced results that de-risk the development of Kanvas Bio’s lead immuno-oncology drug.

Through its proprietary bioprinting technology, Aspect Biosystems creates functional human tissues with unprecedented precision and control. These 3D-printed tissues can restore a diseased state without the constraints of traditional organ transplantation.

Crane NXT, Co. (NYSE: CXT), a premier industrial technology company, today announced that it has completed the acquisition of the Smart Packaging assets of TruTag Technologies.